Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy.
OBJECTIVE
As ionized magnesium is the active form of magnesium and exerts a therapeutic effect, the present study was performed to determine the levels and correlations between ionized and total magnesium under baseline and therapeutic conditions in patients with severe preeclampsia and eclampsia receiving magnesium sulfate.


METHODS
Fifty singleton patients with severe preeclampsia received a loading dose of 4 g of magnesium sulfate, followed by 2 g per hour as maintenance dose until 24 h after delivery, or 24 h after the last seizure in case of postpartum convulsions. Serial blood samples were taken before magnesium sulfate infusion, 30 min and 240 min after the initiation of the infusion and 4 h after the discontinuation of the drug. Data were analyzed by repeated measure ANOVA and paired t-test.


RESULTS
Baseline levels of total and ionized magnesium were 2.4+/-0.6 mEq/L and 1.3+/-0.5 mEq/L (mean+/-SD), respectively. Putative level of 4 mEq/L of total magnesium was not obtained in up to 42% of patients during the treatment. There was not any significant correlation between the two forms of magnesium under baseline and therapeutic conditions.


CONCLUSIONS
Despite the effectiveness of the standard regimen of magnesium sulfate in the treatment and prevention of eclamptic seizures, it can not provide the proposed therapeutic level of magnesium in all patients. With respect to the lack of correlation between ionized and total magnesium, further studies are necessary to investigate the superiority of measurement of ionized, rather than total magnesium, for titration of therapeutic magnesium sulfate infusion.
Aali
Bibi Shahnaz
BS
Department of Obstetrics and Gynecology, Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran. shahnaz_aali@excite.com
Khazaeli
Payam
P
Ghasemi
Fatemeh
F
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004461:Eclampsia / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D013054:Spectrophotometry, Atomic
D000927:Anticonvulsants; D008278:Magnesium Sulfate; D003404:Creatinine